← Back

Sikarin Public Company Limited

Sikarin Public Company Limited, together with its subsidiaries, operates hospitals in Thailand. The company operates diabetes and endocrine center, general medicine clinic, emergency and trauma center, surgery clinic, children's dental center, aesthetic center, laboratory department, diagnostic radiology center, CT scan unit, operating rooms, hemodialysis units, physical therapy department with physical medicine and rehabilitation specialist, catheter laboratory, intensive care units, coronary care units, inpatient wards and international wards, after heart and thoracic surgery ward, medical-surgical ward, and pediatric ward. It also operates woman's health center, health center, fertility center, delivery room, nursery department and the inpatient wards, obstetrics and gynecology ward, stroke center, EENT center, international medical center, orthopedics center, and MRI center. In addition, the company is involved in the management of rental spaces; and sale of food and beverages, as well as restaurant and medical clinic business. The company was founded in 1979 and is headquartered in Bangkok, Thailand.

Price · split & dividend adjusted
News & notes moving SKR.BK
SKR.BK2

Cabinet Expands Social Security, Boosting Hospital Stocks BCH and CHG

The Cabinet meeting approved in principle a draft royal decree to extend Social Security coverage under Section 33 to three groups of employees previously exempted: those in agriculture, forestry, and animal husbandry; employees of individual employers; and employees of stall-holder employers. This is expected to add 550,000 insured persons in 2026 and 1.05 million by 2030. Krungsri Securities views this as a positive sentiment for hospital groups treating insured patients, with upside to revenue in the medium to long term. Hospitals with the highest social security revenue in the first half include BCH at 38% and CHG at 30%, while RJH has 53%, SKR 36%, VIH 26%, and PHG 40%. The firm maintains a bullish stance on the hospital group, expecting profits to have passed the trough, supported by the high season and the increase in social security treatment rates. Top picks are BDMS with a target price of 25 baht and PR9 with a target price of 24 baht. BCH, with a target price of 12 baht, is the biggest beneficiary if treatment rates are adjusted.
HoonVision·1dRead more ▾